Our CommitmentOur Commitment

We are committed to improving the health of people affected by chronic inflammatory and fibrotic diseases.

Learn More

Our CompanyOur Company

We are focused on developing and commercializing medicines that treat inflammatory and fibrotic diseases by targeting the endocannabinoid system.

Learn More

Our ScienceOur Science

We are at the forefront of developing rationally-designed molecules that target the endocannabinoid system to modulate inflammation and fibrosis.

Learn More

Endocannabinoid System Platform has Potential to Deliver Pipeline of Products

2

Lead Compounds

1

Ongoing Late-Stage Clinical Studies

700+

Compounds in Library

>350k

People Affected by Target Diseases

Join Our Team

We are high achievers, creative, innovative and above all else, passionate about what we do.

View Open Positions
A group photo of our team

Sign up for email alerts

Receive breaking news first.

Sign up for updates

Third-party websites are provided for convenience only. Corbus Pharmaceuticals Holdings, Inc. does not approve of, or endorse any of the content. Corbus Pharmaceuticals Holdings, Inc. does not maintain, control or monitor the content of third-party websites in any way.